1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Australia Pharmaceuticals and Healthcare Report Q2 2016

Australia Pharmaceuticals and Healthcare Report Q2 2016

  • April 2016
  • -
  • Business Monitor International
  • -
  • 99 pages

Includes 3 FREE quarterly updates

BMI View: As the Australian government continues to focus on cost containment while at the same timeincreasing the population's access to innovative medicines, companies will increasingly need to justify theprice of their treatments by demonstrating their value to the broader healthcare system in improving thequality of life This will need to be further substantiated by rigorous economic analysis which showcases astrong incremental product cost effectiveness ratio

Headline Expenditure Projections

- Pharmaceuticals: AUD140bn (USD105bn) in 2015 to AUD145bn (USD96bn) in 2016; +34% inlocal currency terms and -86% in US dollar terms, due to significant exchange rate fluctuations

- Healthcare: AUD157bn (USD118bn) in 2015 to AUD162bn (USD108bn) in 2016; +34% in localcurrency terms and -85% in US dollar terms, due to exchange rate fluctuations

Table Of Contents

Australia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Australia 2012-2020) 14
Healthcare Market Forecast 15
Table: Selected Health Measures In Australia FY2015/16 Budget 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Australia 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Australia 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Australia 2012-2020) 25
Generic Drug Market Forecast 26
Table: Cost Of Selected Drugs Post-Price Disclosure, April 2013 28
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Australia 2012-2020) 29
OTC Medicines Market Forecast 30
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Australia 2012-2020) 32
Pharmaceutical Trade Forecast 33
Table: Pharmaceutical Trade Data And Forecasts (Australia 2014-2020) 35
Table: Pharmaceutical Trade Data And Forecasts local currency (Australia 2014-2020) 35
Industry Risk Reward Index 36
Asia Pacific Risk/Reward Index 36
Australia Risk/Reward Index 42
Rewards 42
Risks 43
Regulatory Review 44
Table: EU and ICH Guidelines Adopted In The TGA's Biosimilars Guidance Document 45
Intellectual Property Issues 47
Pricing and Reimbursement Regime 51
Table: Selected Drugs Undergoing SPD (AUD) 52
Table: Historical PBS Co-Payments 53
Table: New PBS Formularies 56
Market Overview 57
Healthcare Sector 57
Research And Development 58
Clinical Trials 59
Epidemiology 60
Competitive Landscape 63
Research-Based Industry 63
Table: Multinational Market Activity 64
Pharmaceutical Distribution 65
Company Profile 67
Australian Pharmaceutical Industries 67
CSL 70
GlaxoSmithKline 74
Mayne Pharma Group 78
Sanofi 81
Sigma 84
Demographic Forecast 88
Table: Population Headline Indicators (Australia 1990-2025) 89
Table: Key Population Ratios (Australia 1990-2025) 89
Table: Urban/Rural Population and Life Expectancy (Australia 1990-2025) 90
Table: Population By Age Group (Australia 1990-2025) 90
Table: Population By Age Group % (Australia 1990-2025) 91
Glossary 93
Methodology 95
Pharmaceutical Expenditure Forecast Model 95
Healthcare Expenditure Forecast Model 95
Notes On Methodology 96
Risk/Reward Index Methodology 97
Index Overview 98
Table: Pharmaceutical Risk/Reward Index Indicators 98
Indicator Weightings 99

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.